Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-23 Sale |
2025-01-27 8:28 pm |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
55,000 | $40.25 | $2,213,997 | 100,700 (Indirect Direct) |
View |
| 2023-05-24 Sale |
2023-05-26 7:10 pm |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
31,655 | $41.41 | $1,310,931 | 45,602 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-12 Option Award |
2025-03-13 7:33 pm |
N/A 2035-03-11 |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
325,000 | $0 | 325,000 (Direct) |
View |
| 2025-01-23 Exercise |
2025-01-27 8:28 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
55,000 | $17.76 | 100,700 (Direct) |
View |
| 2025-01-23 Exercise |
2025-01-27 8:28 pm |
N/A 2025-03-16 |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
55,000 | $0 | 100,700 (Direct) |
View |
| 2024-03-11 Option Award |
2024-03-12 6:33 pm |
N/A 2034-03-10 |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
250,000 | $0 | 250,000 (Direct) |
View |
| 2023-05-24 Exercise |
2023-05-26 7:10 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
42,592 | $9.44 | 45,602 (Direct) |
View |
| 2023-05-24 Tax Withholding |
2023-05-26 7:10 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
12,383 | $41.84 | 45,602 (Direct) |
View |
| 2023-05-24 Exercise |
2023-05-26 7:10 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
26,748 | $9.85 | 45,602 (Direct) |
View |
| 2023-05-24 Exercise |
2023-05-26 7:10 pm |
N/A 2023-07-31 |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
69,340 | $0 | 45,602 (Direct) |
View |
| 2023-03-10 Option Award |
2023-03-14 4:36 pm |
N/A 2033-03-09 |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
380,000 | $0 | 380,000 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 4:15 pm |
N/A 2032-03-09 |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
400,000 | $0 | 400,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-03 4:46 pm |
N/A 2031-06-02 |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CEO |
125,000 | $0 | 125,000 (Direct) |
View |
| 2021-03-12 Option Award |
2021-03-15 4:37 pm |
N/A 2031-03-11 |
Xenon Pharmaceuticals Inc. | XENE | MORTIMER IAN PRESIDENT & CFO |
100,000 | $0 | 100,000 (Direct) |
View |